These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 9345591

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Neurodegenerative movement disorders: the contribution of functional imaging.
    Piccini P.
    Curr Opin Neurol; 2004 Aug; 17(4):459-66. PubMed ID: 15247543
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Measurement of the dopaminergic degeneration in Parkinson's disease with [123I] beta-CIT and SPECT. Correlation with clinical findings and comparison with multiple system atrophy and progressive supranuclear palsy.
    Brücke T, Asenbaum S, Pirker W, Djamshidian S, Wenger S, Wöber C, Müller C, Podreka I.
    J Neural Transm Suppl; 1997 Aug; 50():9-24. PubMed ID: 9120429
    [Abstract] [Full Text] [Related]

  • 26. Molecular imaging by PET.
    Reivich M.
    Adv Exp Med Biol; 2003 Aug; 510():237-41. PubMed ID: 12580434
    [No Abstract] [Full Text] [Related]

  • 27. Chapter 33: the history of movement disorders.
    Lanska DJ.
    Handb Clin Neurol; 2010 Aug; 95():501-46. PubMed ID: 19892136
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Discordant twins with Parkinson's disease: positron emission tomography and early signs of impaired cognitive circuits.
    Holthoff VA, Vieregge P, Kessler J, Pietrzyk U, Herholz K, Bönner J, Wagner R, Wienhard K, Pawlik G, Heiss WD.
    Ann Neurol; 1994 Aug; 36(2):176-82. PubMed ID: 8053653
    [Abstract] [Full Text] [Related]

  • 31. The role of functional neuroimaging in the differential diagnosis of idiopathic Parkinson's disease and multiple system atrophy.
    Eckert T, Eidelberg D.
    Clin Auton Res; 2004 Apr; 14(2):84-91. PubMed ID: 15095050
    [Abstract] [Full Text] [Related]

  • 32. Positron emission tomography in progressive supranuclear palsy.
    Bhatt MH, Snow BJ, Martin WR, Peppard R, Calne DB.
    Arch Neurol; 1991 Apr; 48(4):389-91. PubMed ID: 1901484
    [Abstract] [Full Text] [Related]

  • 33. The role of positron emission tomography in the assessment of human neurotransplantation.
    Sawle GV, Myers R.
    Trends Neurosci; 1993 May; 16(5):172-6. PubMed ID: 7685938
    [Abstract] [Full Text] [Related]

  • 34. PET and SPECT functional imaging in Parkinson's disease.
    Antonini A, DeNotaris R.
    Sleep Med; 2004 Mar; 5(2):201-6. PubMed ID: 15033144
    [Abstract] [Full Text] [Related]

  • 35. [Presynaptic nigrostriatal function in Parkinson disease and Parkinson-plus syndromes. Comparative studies using positron emission tomography with L-6-(18F)fluorodopa].
    Cordes M, Poewe W.
    Nervenarzt; 1994 Oct; 65(10):696-9. PubMed ID: 7808568
    [Abstract] [Full Text] [Related]

  • 36. PET and movement disorders.
    Brooks DJ, Frackowiak RS.
    J Neurol Neurosurg Psychiatry; 1989 Jun; Suppl(Suppl):68-77. PubMed ID: 2666580
    [Abstract] [Full Text] [Related]

  • 37. [Regional cerebral blood flow single photon emission tomography (SPECT) and magnetic resonance imaging (MRI) may be useful in the diagnosis of patients with cortico-basal degeneration, progressive supranuclear palsy and multiple system atrophy].
    Lass P, Sławek J, Derejko M, Dubaniewicz M.
    Neurol Neurochir Pol; 2003 Jun; 37 Suppl 5():263-74. PubMed ID: 15098354
    [Abstract] [Full Text] [Related]

  • 38. Iodine-123-IBF SPECT evaluation of extrapyramidal diseases.
    Buck A, Westera G, Sutter M, Albani C, Kung HF, vonSchulthess GK.
    J Nucl Med; 1995 Jul; 36(7):1196-200. PubMed ID: 7790944
    [Abstract] [Full Text] [Related]

  • 39. Regional metabolic changes in parkinsonian patients with normal dopaminergic imaging.
    Eckert T, Feigin A, Lewis DE, Dhawan V, Frucht S, Eidelberg D.
    Mov Disord; 2007 Jan 15; 22(2):167-73. PubMed ID: 17133454
    [Abstract] [Full Text] [Related]

  • 40. [Iodine 123-labeled meta-iodobenzylguanidine myocardial scintigraphy in the cases of idiopathic Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy].
    Yoshita M, Hayashi M, Hirai S.
    Rinsho Shinkeigaku; 1997 Jun 15; 37(6):476-82. PubMed ID: 9366173
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.